Par Drugs and Chemicals logo

Par Drugs and Chemicals financials and balance sheet

NSE: PARPharmaceuticals & BiotechnologySmall Cap

Last close ₹103.43down ₹1.17 (1.12%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹104.60.

52-week range of traded prices to 23 Oct 2026
₹78.05Low, 30 Mar 2026₹180.00High, 3 Sep 2026
Market cap
₹127 Cr2,825th largest listed
P/E
8.8
P/B
1.1
Dividend yield
Nonein the last 12 months
ROE
13.7%
ROCE
14.5%
Debt to equity
0.00
Volume, NSE
17,979

7 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Par Drugs and Chemicals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹104 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue104
  2. Materials and goods−43
  3. Employee costs−6.1
  4. Other expenses−37
  5. Operating profit17
  6. Depreciation−3.7
  7. Other income+4.0
  8. One-off items0.0
  9. Finance costs−0.1
  10. Profit before tax17
  11. Tax−4.2
  12. Net profit13

What the company owns

  • Plant, investments and other assets₹70 Cr
  • Cash and bank₹42 Cr
  • Receivables₹12 Cr
  • Inventory₹5 Cr

What pays for it: net worth and liabilities

  • Net worth₹112 Cr
  • Other liabilities₹9 Cr
  • Owed to suppliers₹8 Cr

Profit and loss

Standalone, ₹ crore, years to March.Par Drugs and Chemicals quarterly results

₹ croreMar 2020Mar 2021Mar 2022Filed 7 MayMar 2023Filed 28 AprMar 2024Filed 10 MayMar 2025Filed 8 MayMar 2026Filed 14 May
Revenue from operations5661759696101104
46455978738187
Materials and goods bought24222940343843
Employee costs4445566
Other expenses19192632343737
Operating profit before depreciation9161618232017
Operating margin16.9%26.4%21.7%19.0%23.9%19.3%16.5%
Materials, % of revenue42.4%36.0%38.4%42.1%35.3%37.8%41.8%
Employee costs, % of revenue7.4%6.5%5.5%5.1%5.7%5.8%5.9%
Other expenses, % of revenue33.4%31.1%34.5%33.8%35.1%37.1%35.7%
Depreciation and amortisation3333344
Operating profit after depreciation7131315191613
Other income0000024
Finance costs1100000
One-off items0000000
Profit before tax6131315201817
1–34554
Net profit50911151313
Net margin8.5%0.0%12.3%11.8%15.2%13.2%12.6%
Tax is left blank for the year to Mar 2021: profit before tax less the tax charge stated does not come to the profit after tax the same statement states, so the tax charge is not shown.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2023Filed 28 AprMar 2024Filed 10 MayMar 2025Filed 8 MayMar 2026Filed 14 May
718699112
Share capital12121212
Reserves597387100
Borrowings0000
14121714
4443
Total assets89102119129
39426565
49605564
Net debt−22−37−28−42
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2020, Mar 2021 and Mar 2022, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2022Filed 7 MayMar 2023Filed 28 AprMar 2024Filed 10 MayMar 2025Filed 8 MayMar 2026Filed 14 May
7.613.420.216.216.4
10.717.624.620.721.5
−5.4−0.52.00.22.4
Receivables−6.01.53.3−3.04.7
Inventories−1.7−0.71.2−1.90.7
Payables3.9−2.6−2.75.5−2.7
Other working capital−1.61.30.3−0.4−0.3
Tax paid−3.1−4.3−4.4−4.5−5.0
Capital spending3.27.66.11.32.0
Free cash flow4.45.714.214.914.5
−3.0−7.3−5.8−25.2−2.2
−9.60.00.00.00.0
Dividends paid1.50.00.00.00.0
Shares bought back0.00.00.00.00.0
Shares issued0.00.00.00.00.0
Net change in cash−5.06.014.4−9.114.3
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2020 and Mar 2021.

Per share

Standalone, ₹ per share, years to March.Par Drugs and Chemicals dividend history

₹ per shareMar 2020Mar 2021Mar 2022Filed 7 MayMar 2023Filed 28 AprMar 2024Filed 10 MayMar 2025Filed 8 MayMar 2026Filed 14 May
Earnings per share––₹7.49₹9.21₹11.78₹10.86₹10.65
Diluted earnings per share––₹7.49₹9.21₹11.78₹10.86₹10.65
₹1.25–₹1.25––––
As declared that year₹2.50–₹1.25––––
Book value per share–––₹57.90₹69.59₹80.44₹91.01
Dividend payout––16.7%––––
Shareholder yield––0.8%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)––19717226510597
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.
RatioMar 2020Mar 2021Mar 2022Filed 7 MayMar 2023Filed 28 AprMar 2024Filed 10 MayMar 2025Filed 8 MayMar 2026Filed 14 May
Revenue growth–8.8%23.6%27.5%−0.1%5.6%2.7%
Operating profit growth–69.5%1.5%12.0%25.3%−14.5%−12.2%
Net profit growth–−100.0%46,07,450.0%23.0%27.9%−7.9%−1.9%
Earnings per share growth–––23.0%27.9%−7.8%−1.9%
–––15.9%18.5%14.5%12.4%
––––2.6 pts−4.0 pts−2.0 pts
From the net margin––––4.5 pts−2.4 pts−0.6 pts
From asset turnover––––−1.4 pts−1.5 pts−1.2 pts
From borrowing––––−0.5 pts−0.2 pts−0.2 pts
Return on capital employed–––21.0%22.6%16.0%12.0%
Cash conversion––82.6%118.0%139.6%121.0%125.4%
Interest cover8.420.528.6112.4181.0193.1105.5
Debt to equity–––0.000.000.000.00
Receivable days–––65526042
Inventory days–––49455845
Payable days–––735810469
Cash conversion cycle, days–––40401519
Working capital days–––50403931
Asset turnover–––1.081.000.910.83
Assets per rupee of net worth–––1.251.211.201.18
Sales per rupee of plant–––2.492.322.592.84
Capital spending to depreciation––0.982.361.770.340.53
Plant being built, % of plant in use–––0.6%0.1%0.0%2.0%
No balance sheet is on record for the years to Mar 2020, Mar 2021 and Mar 2022, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
10.5%
Cash from operations against operating profit
95.9%
Measure5 years3 years
Revenue growth, yearly rate11.3%2.7%
Profit growth, yearly rate819.0%5.0%
Return on equity, average15.3%15.1%
Return on capital employed, average17.9%16.9%
Operating margin, average20.1%19.9%
Net margin, average13.0%13.7%
Asset turnover, average0.960.92
Cash conversion cycle, days, average2824
Interest cover, average124.1159.9
Debt to equity, average0.000.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations73.852.816.4
Cash from investing−43.6−33.2−2.2
Cash from financing−9.60.00.0
Capital spending20.19.32.0
Dividends paid1.50.00.0
Shares bought back0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised0.00.00.0
Borrowings repaid7.60.00.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9–––––45
Altman Z-scorePublished threshold 1.81–––8.9113.105.826.16
Beneish M-scorePublished threshold −1.78––––−3.07−2.56−2.25
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––0.0920.30−0.93
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––1.181.271.29
Receivables growth less revenue growthOur threshold 0 percentage points––––−19.0716.30−30.69
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––––−6.1433.34−25.73
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––––0.22−0.610.59
Assets under construction, years of additionsOur threshold 2 years of additions––––0.000.000.58
Effective tax ratePublished threshold 17.16 per cent20.4824.4527.4624.8425.7025.4724.23
Tax charged less tax paid, % of profitOur threshold 10 percentage points––2.87−3.443.360.19−4.83
A threshold marked as ours has no published figure; it is the line we read the check against.